Jon Riise

3PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 22, 2025
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma.

Leo Meriranta, Rasmus Rask Kragh Jørgensen, Annika Pasanen

|Dec 19, 2023
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial.

Mats Jerkeman, Arne Kolstad, Martin Hutchings

|Mar 07, 2022
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination.

Jon Riise, Saskia Meyer, Isaac Blaas

Pageof 1